Nyrada (ASX:NYR) Ending Cash Position : A$4.65 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Nyrada Ending Cash Position?

Nyrada's Ending Cash Position for the quarter that ended in Dec. 2023 was A$4.65 Mil.

Nyrada's quarterly Ending Cash Position declined from Dec. 2022 (A$9.34 Mil) to Jun. 2023 (A$3.71 Mil) but then increased from Jun. 2023 (A$3.71 Mil) to Dec. 2023 (A$4.65 Mil).

Nyrada's annual Ending Cash Position declined from Jun. 2021 (A$13.75 Mil) to Jun. 2022 (A$10.82 Mil) and declined from Jun. 2022 (A$10.82 Mil) to Jun. 2023 (A$3.71 Mil).

Nyrada Ending Cash Position Historical Data

The historical data trend for Nyrada's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyrada Ending Cash Position Chart

Nyrada Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

5.15

13.75

10.82

3.71

Nyrada Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial			11.11	10.82	9.34	3.71	4.65

Nyrada Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Nyrada's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10.816	+	-7.107
	=	3.71

Nyrada's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.709	+	0.936
	=	4.65

Nyrada Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Nyrada's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyrada (ASX:NYR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nyrada Inc (ASX:NYR) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

828 Pacific Highway, Suite 2, Level 3, Gordon, NSW, AUS, 2072

Website

https://www.nyrada.com

Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

Nyrada (ASX:NYR) Headlines

No Headlines